Congress mandates free contraceptive coverage—if FDA approves OTC pills
S. 5539 — Affordability is Access Act of 2026 · Filed by Patty Murray (D-WA) · 32 cosponsors · Introduced Sep 24, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires health insurance plans to cover over-the-counter contraceptives without cost-sharing (no copays, deductibles, or coinsurance) once the FDA approves them for sale without a prescription. It also clarifies that existing law already requires coverage of all FDA-approved prescription contraceptives, and directs retailers stocking OTC contraceptives not to interfere with customers' ability to purchase them.
Why we flagged it
The bill's core mechanism is a mandate requiring health insurers to cover FDA-approved over-the-counter contraceptives without cost-sharing, expanding access to reproductive healthcare. This is a straightforward public-health measure with no hidden provisions or narrow beneficiaries.
What the text implies
- Depends on FDA approval of OTC oral contraceptives, which has not yet occurred; bill's practical impact is contingent on pharmaceutical companies submitting applications and FDA granting approval.
- Section 7(b) permits retailers to refuse sale if customer cannot pay directly or through insurance/other mechanism, creating a potential loophole that could limit access despite insurance coverage requirement.
- Clarification of existing ACA § 2713 mandate may trigger litigation from religious employers and insurers claiming conscience objections, potentially narrowing coverage in practice.
- Bill does not address non-insurance barriers (pharmacy access, transportation, childcare) that may prevent individuals from obtaining contraceptives even if covered.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill removes cost barriers to contraceptive access for millions of people, particularly those with lower incomes and historically marginalized groups who face disproportionate barriers to reproductive healthcare. Expanded coverage without cost-sharing directly lowers out-of-pocket expenses and increases contraceptive choice.
Who stands to gain
- pharmaceutical companies developing OTC contraceptives
- retail pharmacies and drugstores (increased OTC contraceptive sales volume)
Named in the bill
Food and Drug Administration (FDA), Department of Health and Human Services, Department of Labor, Department of the Treasury, Patient Protection and Affordable Care Act (ACA), Public Health Service Act § 2713, Federal Food, Drug, and Cosmetic Act
Where it stands
32 cosponsors: 31 Democrats, 1 Independents.
- Sep 24, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Sep 24, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
6 lobbying clients named this bill on 6 disclosure filings across 1 quarter, Sep 2026 to Sep 2026. Those filings disclosed $397,101 in lobbying spend. A filing names 48 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 79% of bills with at least one filing.
Patty Murray, the sponsor, reported $336,200 in PAC receipts in the 2026 cycle.
- Planned Parenthood Federation of America Inc — $308,925 on 1 filing
- National Women's Law Center Action Fund — $50,000 on 1 filing
- Power to Decide — $18,176 on 1 filing
- National Council of Jewish Women — $10,000 on 1 filing
- Reproductive Freedom for All — $10,000 on 1 filing
Lobbying Disclosure Act filings through Oct 22, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (6,853 characters) on Sep 26, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Sep 2026 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Oct 22, 2026 · page rendered 2026-11-22.
“Congress mandates free contraceptive coverage—if FDA approves OTC pills” QuorumCivic. https://share.quorumcivic.app/bill/119/s5539 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.